Related Experiment Videos
Multidrug resistance--a fascinating, clinically relevant problem in bioenergetics
1Department of Biological Chemistry, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205-2185, USA.
Journal of Bioenergetics and Biomembranes
|February 1, 1995
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy.
Medical oncology (Northwood, London, England)·2022
Preparation of Ultracold Atom Clouds at the Shot Noise Level.
Physical review letters·2016
The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.
Journal of bioenergetics and biomembranes·2016
Basal and T₃-induced ROS production in lymphocyte mitochondria is increased in type 2 diabetic patients.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2012
The role of mitochondrial Na⁺/Ca²⁺ exchanger in brain cell aging.
Journal of bioenergetics and biomembranes·2026
Succinate and lactate produced as conserved biomarkers through chronic and transient substrate-level phosphorylation: from microorganisms to cancer.
Journal of bioenergetics and biomembranes·2026
DNMT1 methylates E3 ligase FBXO32 to regulate Myc stability and glycolytic reprogramming in diabetic retinopathy associated endothelial cells.
Journal of bioenergetics and biomembranes·2026
Targeting MEK1/2 inhibits mitochondrial respiration and redox homeostasis in resistant rectal cancer.
Journal of bioenergetics and biomembranes·2026
Intestinal microecology regulates neutrophil recruitment through TLR4/MAPK/CXCR2 signaling pathway to promote liver ischemia/reperfusion injury.
Journal of bioenergetics and biomembranes·2026
Myelin Alteration in Neurodevelopmental Disorders: Integrating Clinical and Preclinical Evidence.
Current neuropharmacology·2026
Enhanced transcriptional insulation of lentiviral vectors using "sequence-upgraded polyA long terminal repeats" or "supA-LTRs".
Molecular therapy. Advances·2026